[开发新的基因修饰T细胞疗法 (CAR-T,TCR-T) ]
1Dept. of Advanced Medical Development, The Cancer Institute Hospital of JFCR.
Gan to kagaku ryoho. Cancer & chemotherapy
|November 30, 2023
概括
基因改造的T细胞疗法,如CAR-T,对血液癌症有很大的前景,并且在固体瘤方面取得了进展. 未来的研究面临着这些创新治疗的固体瘤应用的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 自2000年代以来,化学抗原受体 (CAR) -T细胞治疗和T细胞受体 (TCR) -T细胞治疗的发展一直很活跃.
- CD19-CAR-T疗法已被批准用于B细胞淋巴瘤/白血病,以及针对多发性骨髓瘤的BCMA向的CAR-T.
- 针对固体瘤的CAR-T疗法正在开发中,目前尚未获得批准.
研究的目的:
- 审查基因修饰T细胞治疗固体瘤的当前发展状况.
- 确定将这些疗法应用于固体瘤的未来挑战.
主要方法:
- 关于CAR-T和TCR-T疗法的科学文献和临床试验数据的审查.
- 对最近的进展进行分析,包括针对MHC-复合物的CAR-T.
主要成果:
- 已批准的CAR-T疗法存在于特定的血液性恶性瘤.
- 固体瘤的CAR-T疗法开发正在进行中,但面临着重大障碍.
- 针对MHC-复合体的新型CAR-T策略正在出现.
结论:
- 基因改造的T细胞疗法代表了癌症治疗的重大进展.
- 克服固体瘤微环境中的挑战对于治疗成功至关重要.
- 持续的研究和开发对于扩大T细胞疗法的应用到固体瘤至关重要.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
T Cell Activation and Clonal Selection
743
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
743


